Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hare

Showing results (641-650 of 873) with videos related to

Pageof 88
Sort By:
Journal of the American College of Cardiology|November 18, 2017
A Combination of Allogeneic Stem Cells Promotes Cardiac RegenerationMakoto Natsumeda, Victoria Florea, Angela C Rieger, et al.
European Heart Journal Open|March 23, 2023
Intramyocardial cell-based therapy with Lomecel-B during bidirectional cavopulmonary anastomosis for hypoplastic left heart syndrome: the ELPIS phase I trialSunjay Kaushal, Joshua M Hare, Jessica R Hoffman, et al.
BMJ Open|February 5, 2025
Azithromycin to prevent acute lower respiratory infections among Australian and New Zealand First Nations and Timorese children (PETAL trial): study protocol for a multicentre, international, double-blind, randomised controlled trialGabrielle B McCallum, Catherine A Byrnes, Peter S Morris, et al.
Psychiatry Research. Neuroimaging|January 21, 2023
Five negative symptom domains are differentially associated with resting state amplitude of low frequency fluctuations in SchizophreniaEun-Jin Cheon, Alie G Male, Bingchen Gao, et al.
Circulation Research|April 29, 2018
Rationale and Design of the CONCERT-HF Trial (Combination of Mesenchymal and c-kit<sup>+</sup> Cardiac Stem Cells As Regenerative Therapy for Heart Failure)Roberto Bolli, Joshua M Hare, Keith L March, et al.
JAMA|November 3, 2012
Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trialJoshua M Hare, Joel E Fishman, Gary Gerstenblith, et al.
Cell Metabolism|October 7, 2015
Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular HypertrophyAlexander Grabner, Ansel P Amaral, Karla Schramm, et al.
The Journal of Cardiovascular Aging|July 30, 2021
Editors' Preamble to <i>The Journal of Cardiovascular Aging</i>Ali J Marian, Babken Asatryan, Roberto Bolli, et al.
Neuroimage|August 13, 2022
Cerebral blood flow and cardiovascular risk effects on resting brain regional homogeneityBhim M Adhikari, L Elliot Hong, Zhiwei Zhao, et al.
Circulation Research|January 23, 2014
Does transendocardial injection of mesenchymal stem cells improve myocardial function locally or globally?: An analysis from the Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis (POSEIDON) randomized trialViky Y Suncion, Eduard Ghersin, Joel E Fishman, et al.
Pageof 88

Showing results (641-650 of 873) with videos related to

Sort By:
Pageof 88
Journal of the American College of Cardiology|November 18, 2017
A Combination of Allogeneic Stem Cells Promotes Cardiac RegenerationMakoto Natsumeda, Victoria Florea, Angela C Rieger, et al.
European Heart Journal Open|March 23, 2023
Intramyocardial cell-based therapy with Lomecel-B during bidirectional cavopulmonary anastomosis for hypoplastic left heart syndrome: the ELPIS phase I trialSunjay Kaushal, Joshua M Hare, Jessica R Hoffman, et al.
BMJ Open|February 5, 2025
Azithromycin to prevent acute lower respiratory infections among Australian and New Zealand First Nations and Timorese children (PETAL trial): study protocol for a multicentre, international, double-blind, randomised controlled trialGabrielle B McCallum, Catherine A Byrnes, Peter S Morris, et al.
Psychiatry Research. Neuroimaging|January 21, 2023
Five negative symptom domains are differentially associated with resting state amplitude of low frequency fluctuations in SchizophreniaEun-Jin Cheon, Alie G Male, Bingchen Gao, et al.
Circulation Research|April 29, 2018
Rationale and Design of the CONCERT-HF Trial (Combination of Mesenchymal and c-kit<sup>+</sup> Cardiac Stem Cells As Regenerative Therapy for Heart Failure)Roberto Bolli, Joshua M Hare, Keith L March, et al.
JAMA|November 3, 2012
Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trialJoshua M Hare, Joel E Fishman, Gary Gerstenblith, et al.
Cell Metabolism|October 7, 2015
Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular HypertrophyAlexander Grabner, Ansel P Amaral, Karla Schramm, et al.
The Journal of Cardiovascular Aging|July 30, 2021
Editors' Preamble to <i>The Journal of Cardiovascular Aging</i>Ali J Marian, Babken Asatryan, Roberto Bolli, et al.
Neuroimage|August 13, 2022
Cerebral blood flow and cardiovascular risk effects on resting brain regional homogeneityBhim M Adhikari, L Elliot Hong, Zhiwei Zhao, et al.
Circulation Research|January 23, 2014
Does transendocardial injection of mesenchymal stem cells improve myocardial function locally or globally?: An analysis from the Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis (POSEIDON) randomized trialViky Y Suncion, Eduard Ghersin, Joel E Fishman, et al.
Pageof 88